The Pharmaceutical Care Management Association—a trade lobby representing pharmacy benefit managers—argues a state law that would force companies to divest from drugstores could leave patients without access to critical medications.

Among healthcare organizations sweating the possible passage of the “One Big Beautiful Bill,” few have more to worry about than nonprofit hospitals and health systems that compete with privately held or publicly traded rivals for executive talent.

STAT said it was sent an internal memo by accident, wherein UnitedHealth Group leadership outlines its messaging to navigate disgruntled investors upset with the direction of the company.

We’re either teetering at the edge of AI overlordship—or just working with new tech tools that do the same old computer-y things we’ve always done. So which is it? 

Returning CEO Stephen Hemsley will receive a base salary of $1 million per year, alongside a one-time bonus package in stocks worth $60 million. He is not eligible to receive future bonuses until 2028, the company confirmed in a SEC filing. 

The acquisition would allow Ascension—a nonprofit health system—to expand its outpatient surgery network, as Amsurg operates 250 centers nationwide. Sources said a final deal could be mere weeks away. 

A new report from the American Medical Association reveals that doctors are increasingly likely to work for larger provider groups and hospitals, as single specialty practices slowly disappear. 

The newly signed law, known as Act 264, bans pharmacy benefit managers from owning pharmacies in the state. It's scheduled to go into effect beginning in 2026.